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by high-gradient magnetic ﬁshing
Cláudia SG Gomes,a† Adedayo Fashina,b Alfred Fernández-Castané,b‡
TimothyWOverton,b Timothy J Hobley,c Eirini Theodosioud* and
Owen RT Thomasb*
Abstract
BACKGROUND: The extraction of biopharmaceuticals from plasma and serum often employs overly complicated antiquated
procedures that can inﬂict serious damage on especially prone protein targets and which aﬀord low puriﬁcation power
and overall yields. This paper describes systematic development of a high-gradient magnetic ﬁshing process for recovery of
immunoglobulins from unclariﬁed antiserum.
RESULTS: Non-porous superparamagnetic particles were transformed into hydrophobic-charge induction adsorbents and then
used to recover immunoglobulins from rabbit antiserum feedstocks. Comprehensive characterisation tests conducted with
variously diluted clariﬁed antiserumon amagnetic rack revealed that immunoglobulin bindingwas rapid (equilibrium reached
in<45 s), strong (Kd< 0.1mgmL
-1), ofhighcapacity (Qmax = 214mgg-1), andpHand ionic strengthdependent. Inahigh-gradient
magnetic ﬁshing process conductedwith the same adsorbent, and a conventional ‘magnetic ﬁlter+ recycle loop’ arrangement,
>72% of the immunoglobulin present in an unclariﬁed antiserum feed was recovered in 0.5 h in>3-fold puriﬁed form.
CONCLUSIONS: Fast magnetic particle based capture of antibodies from an unclariﬁed high-titre feed has been demonstrated.
Eﬃcient product recovery from ultra-high titre bioprocess liquors by high-gradient magnetic ﬁshing requires that improved
magnetic adsorbents displaying high selectivity, ultra-high capacity and operational robustness are usedwith ‘state-of-the-art’
rotor–stator magnetic separators.
© 2018 The Authors. Journal of Chemical Technology&Biotechnology published by JohnWiley & Sons Ltd on behalf of Society of
Chemical Industry.
Keywords: direct capture; polyclonal and monoclonal antibodies; 4-mercaptoethylpyridine; serum and plasma; complex unclariﬁed
bioprocess liquors
INTRODUCTION
The markets for blood-derived protein products are large, and
growing, albeit not fast enough tomeet escalating global needs.1,2
Among recognised factors hindering growth are: increased com-
petition from recombinant alternatives; high cost and limited
procurement of pooled plasma starting material, meaning that
several therapeutic products must be extracted from the same
pool; and continued reliance on antiquated overly expensive and
complex production processes.2,3
Outdated puriﬁcation methods also persist within the immun-
odiagnostics sector and in large-scale commercial processing of
animal plasmas. For example, multiple steps of ammonium sul-
phate precipitation, dialysis and ion exchange batch adsorption
are commonly employed in the production of polyclonal antibod-
ies from serum for diagnostic kit applications,4–6 and harsh pre-
cipitation principles are likewise common in recovery operations
for target proteins from equine plasmas, often compromising the
extraction of other protein products.7–9
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Immunoglobulins are currently the most important
blood-derived product, accounting for nearly 50% of the global
plasma proteins market (cf. 10–15% each for plasma-derived
Factor VIII and albumin), but their recovery (by multiple precip-
itation steps followed by ion exchange chromatography) incurs
large losses during precipitation.3,10,11 In recognition of this,
and in response to increasing market demands for polyclonal
immunoglobulins as biotherapeutics, new approaches (largely
chromatographic), able to simultaneously improve product recov-
ery, purity and productivity, are gradually replacing the three-step
ethanol fractionation process.3,10,11
Ion exchange is the preferred chromatographic technique for
commercial recovery and puriﬁcation of polyclonal antibody ther-
apeutics fromhumanplasma.10 Protein A aﬃnity chromatography,
the lynchpin puriﬁcation technique in industrial manufacture and
production of clinical grade monoclonal antibodies,12 is not
employed and neither is Protein G aﬃnity chromatography.3,10
Protein A fails to bind all human IgG subclasses, particularly IgG3,
which contributes to the humoral viral defence. Protein G on the
other hand binds all subclasses of IgG, but the strongly acidic
elution conditions required are too harsh for a subpopulation of
polyclonal human IgG.10 Additional negating factors for chro-
matography on Protein A/G columns are potential ligand
leaching10 concerns, and unacceptably high media costs10,13
for purifying huge quantities of polyclonal antibodies (global
production of intravenous immunoglobulins reached 140 tonnes
in 201413).
Though well adapted to the fractionation and polishing of
pre-puriﬁed plasma fractions and processing of monoclonal anti-
body culture supernatants, ﬁxed bed chromatography is less well
suited to product capture from much more complex plasma and
serum feeds.9,14 The presence of troublesome fouling components
within these feeds, especially suspended lipoproteinaceousmate-
rials, can severely compromise chromatographic operations; the
extent to which this occurs is largely governed by the nature of
the immobilised ligand and that of base matrix to which it is
attached.5,6,15
The requirement for extensive clariﬁcation before loading
biological feedstocks on ﬁxed bed chromatography columns
is essential, as suspended solids within them become trapped
in the interstitial space between media particles, rapidly cut-
ting oﬀ liquid ﬂow through the bed and posing unacceptable
demands on CIP/SIP. In stark contrast, modern direct capture
techniques, such as expanded bed adsorption and high-gradient
magnetic ﬁshing (HGMF), are suited to fast recovery of target
species from large volumes of unclariﬁed biological liquors,15–18
aﬀord potential improvements in product yield, productivity and
process eﬃciency cf. conventional clariﬁcation followed by ﬁxed
bed chromatography, and importantly, both methods have been
successfully applied for product recovery from plasma/serum
feeds.9,14 HGMF, a scaleable technique combining adsorption
of a product of interest onto low-cost functionalised magnetic
particles, with subsequent retrieval and processing of the product
ladenmagnetic support bymeans of high-gradientmagnetic sep-
aration (HGMS) technology,18–21 aﬀords a fast and eﬃcient means
for isolating protein products from crude feedstocks.9,15,18,21–27
Here we describe systematic development of an HGMF process
for the capture and puriﬁcation of polyclonal antibodies from an
unclariﬁed rabbit antiserum feedstock, employing non-porous
superparamagnetic adsorbents functionalised with the
hydrophobic-charge induction ligand, 4-mercaptoethylpyridine
(4-MEP). The choice of 4-MEP as ligand was informed by a
previous study6 that compared the suitability of eight commercial
chromatography media intended for antibody puriﬁcation, for
capture and puriﬁcation of polyclonal immunoglobulins from
complex clariﬁed rabbit antiserum feeds. Of the ﬁve lowmolecular
class synthetic ligand based media tested, only the hydrophobic
charge induction matrix MEP HyperCel compared favourably with
the much more expensive rProtein A based media.
Four diﬀerent activation routes were employed for anchoring
4-MEP to a favoured magnetic support particle. The resulting
adsorbents were subsequently screened in small-scale magnetic
rack tests for their ability to purify immunoglobulins from a clari-
ﬁed antiserum feedstock, and the best of these was selected for all
further work. Subsequently conditions for optimal use of the cho-
sen MEP-linked magnetic adsorbent for immunoglobulin capture
and puriﬁcation were systematically established, and the adsor-
bent holding capacity of a small high-gradient magnetic ﬁlter unit
positioned in the bore of a mini-pilot scale ‘ON–OFF’ permanent
HGMS unit was determined. Eﬃcient use of MEP-linked magnetic
adsorbents was then demonstrated at sevenfold increased scale
in an HGMF process to recover immunoglobulin in substantially
pure form and high yield from a ‘dirty’ i.e. unclariﬁed, antiserum
feed. The study concludes with a discussion of some of the mea-
sures required to maximise HGMF’s untapped potential as a direct
capture technology for fast recovery of target antibodies andother
proteins expressed at high titre in complex unclariﬁed bioprocess
liquors.
EXPERIMENTAL
Materials
The 430 stainless steel wire matrix (KnitMesh type 9029) and the
rabbit anti-human transferrin antiserum employed in this work
were received as gifts from KnitMesh Ltd (South Croydon, Surrey,
UK) and Dako Agilent Pathology Solutions (Glostrup, Denmark),
respectively. Iron (II) chloride hexahydrate, dimethyl sulphoxide
(99.5%) and Silica gel 60 F254 plates for thin-layer chromatogra-
phy (TLC) were supplied by Merck (Darmstadt, Germany), while
iron (III) tetrahydrate was purchased from Mallinckrodt Baker
B.V. (Deventer, the Netherlands). The following materials were
purchased from the Sigma-Aldrich (St. Louis, MI, USA): thio-
lacetic acid; 4-vinylpyridine; diethyl ether; sodium bicarbonate;
sodium chloride; anhydrous magnesium sulphate; hydrochlo-
ric acid; isopropanol; deuterium oxide; methanol; glacial acetic
acid; 3-aminopropyltriethoxysilane; glycerol; glutaraldehyde
(50%, photographic grade); sodium borohydride; sodium car-
bonate; epichlorohydrin (ECH); allyl bromide (AB); allyl glycidyl
ether (AGE); divinyl sulphone (DVS); N-bromosuccinimide (NBS);
Trizma® base (≥99%); ammonium sulphate; citric acid mono-
hydrate; sodium citrate dihydrate; anhydrous sodium acetate;
and, protein standard (bovine serum albumin). All the reagents
for the rabbit immunoglobulin immunoturbidimetric assay (i.e.
dilution buﬀer – S2005; reaction buﬀer – S2008; goat anti-rabbit
immunoglobulins ‘GoaRbIg’ – Z0421; dilution buﬀer for GoaR-
bIg – TO 0463; and Ig standard – X0903 concentrate), were
obtained from Dako Agilent Pathology Solutions (Glostrup, Den-
mark). Bicinchoninic acid (BCA) protein assay kits were supplied
by Pierce (Rockford, IL, USA), while pre-cast Invitrogen branded
SDS-PAGEgels, NovexColloidal Blueprotein staining kit,molecular
weight markers (myosin – 200 kDa, 𝛽 –galactosidase – 116.3 kDa,
phosphorylase b – 97.5 kDa, bovine serum albumin – 66.2 kDa;
glutamate dehydrogenase – 55.4 kDa, ovalbumin – 45 kDa,
carbonic anhydrase – 31 kDa, trypsin inhibitor – 21.5 kDa,
wileyonlinelibrary.com/jctb © 2018 The Authors. J Chem Technol Biotechnol 2018; 93: 1901–1915
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lysozyme – 14.4 kDa; aprotinin – 6.5 kDa), sample and running
buﬀers were acquired from Thermoﬁsher (Waltham, MA, USA).
All other materials not identiﬁed above were acquired from
Sigma-Aldrich and Merck.
Synthesis of 4-mercaptoethylpyridine hydrochloride
The hydrophobic-charge induction ligand used in this work,
4-mercaptoethylpyridine HCl, was prepared using a modiﬁed ver-
sionof themethoddescribedbyBurton.28 Under stirring 125mLof
4-vinylpyridine (95%) was pre-chilled to –30∘C in a methanol/dry
ice bath. Thiolacetic acid (85mL) was then added at a rate of
0.5mL per min and the temperature was maintained at –23∘C by
immersing the reaction vessel in a water bath held at 20 ± 2∘C.
After 15 h stirring at room temperature, the product was mixed
with 200mL of diethyl ether and extracted four times with 160mL
portions of saturated sodium bicarbonate solution. The separated
ether layer was subsequently washed twice with 150mL portions
of saturated sodium chloride, treated with activated charcoal to
reduce colour, dried over anhydrous magnesium sulphate, then
ﬁltered and evaporated under vacuum (bath temperature∼30∘C).
The resulting oil was stirred with 400mL of 6mol L-1 HCl. After 4 h
the acid layer was reduced under vacuum, the dried residue was
re-slurriedwith 150mLof isopropanol and recrystallised overnight
at –18∘C, before ﬁltering and ﬁnally drying under vacuum to yield
a dark creamy solid. This was then re-dissolved in another 400mL
portion of 6mol L-1 HCl and stirred at room temperature. The reac-
tion was monitored by TLC and stopped after 40 h. Subsequent
concentration, re-crystallisation from 150mL of isopropanol,
ﬁltration and drying gave a creamy white solid (81 g, 40% yield)
identiﬁed as the desired compound: 1H NMR (D2O, 300MHz) 𝛿
2.89 (t, 2 H, CH2-SH, J 7.1 Hz), 3.18 (t, 2 H, Pyr-CH2, J 7.1 Hz), 7.89
(d, 2 H, H-2, H-2′, Pyr, J 6.6 Hz), 8.59 (d, 2 H, H-3, H-3′, Pyr, J 6.8 Hz);
13C NMR (D2O, 300MHz) 𝛿 23.27 (CH2-SH), 39.22 (Pyr-CH2), 127.85
(Pyr, C-3, C-3′), 140.64 (Pyr, C-2, C-2′), 162.44 (Pyr, C-4).
Support handling
A strong (>0.5 T) NdFeB permanent magnet block (Danfysik A/S,
Jyllinge, Denmark) was used to separate magnetic particles from
liquid phases during preparation of themagnetic adsorbents (10 g
scale). In small-scale functionalisation steps and in batch binding
studies, magnetic adsorbents were recovered from suspension
with the aid of ∼0.15 T side-pull NdFeB racks (chemagic Stands
50 k Type A and 2× 12, PerkinElmer chemagen Technolgie GmbH,
Baesweiler, Germany).
Manufacture of 4-mercaptoethylpyridine-linked
superparamagnetic adsorbents
The construction ofMEP-linkedmagnetic adsorbents employed in
this study is shown schematically in Fig. 1 and described below.
Basematerials
Detailed steps for the preparation of polyglutaraldehyde (PG)
coated magnetic starting materials have been presented in full
elsewhere20,29,30 and are only brieﬂy summarised here. 10 g of
cation deﬁcient superparamagnetic iron oxide crystals were pre-
pared by chemical precipitation involving aqueous mixed iron
chloride salts and a strong base. These crystals were subsequently
formed into submicron-sized particles by performing silanisa-
tion with 3-aminopropyltriethoxysilane (3-APTES) in a high-shear
environment, and then stabilising the aminosilane coat by cur-
ing the magnetic particles in glycerol at high temperature under
nitrogen.20 The resulting amine-terminated superparamagnetic
particles were then coated with a layer of polyglutaraldehyde by
stirring with 2% (v/v) glutaraldehyde at pH 11 in a pH stat vessel29
to yield irregular particles (Dv50 = 0.80 μm,Dv20–80 of 0.65–1.12 μm)
with high saturationmagnetisation (MS = 53.3± 2.1 Am2 kg-1) and
low remanence (MR = 0.28± 0.09 Am2 kg-1).
Activation
Next, PG-coated supports were variously activated (as described
previously by Heebøll-Nielsen et al.23,30) before coupling with
4-MEP to produce the four diﬀerent MEP-linked supports des-
ignated Types I–IV (Fig. 1). The manufacture of type I supports
involved prior activation of PG-coated particles (25 g L-1) for 6 h at
21∘C with 5% (v/v) epichlorohydrin (ECH) in 0.5mol L-1 NaOH and
19mmol L-1 NaBH4. The preparation of type II and III MEP-linked
supports involved activation with allyl bromide (AB) and allyl
glycidyl ether (AGE), respectively, using a procedure adapted
from Burton and Harding.31 PG-coated supports (33 g L-1) sus-
pended in 0.15mol L-1 NaOH and 36mmol L-1 NaBH4 in 50% (v/v)
DMSO were mixed with AB (type II) or AGE (type III) to a ﬁnal
concentration of 50% (v/v), incubated for 48 h at room tem-
perature and then washed extensively with water. The result-
ing allylated particles (20 g L-1) were reacted (1 h, 21∘C) with
0.14mol L-1 N-bromosuccinimide (NBS) introducing reactive bro-
mohydrinmoieties. Finally, the creation of type IVmagnetic adsor-
bents involved DVS-activation. In this procedure, DVS was added
at regular intervals over 600 s to PG-coated support particles
(25 g L-1) in 0.5mol L-1 Na2CO3 containing 18mmol L
-1 NaBH4 to a
ﬁnal amount of 8mLg-1 particles. The reaction was subsequently
allowed to proceed for 1 h at room temperature.
Coupling
Before coupling, all activated supports were washed exten-
sively with water by repeated cycles of resuspension, mixing
and magnetic separation. The pH of a 0.7mol L-1 solution of
4-mercaptoethylpyridine HCl in water was adjusted to 11.5 with
saturated NaOH and subsequently diluted to 55mmol L-1 in
0.5mol L-1 Na2CO3 containing 28mmol L
-1 NaBH4. Portions of
this solution were then mixed with ∼1 g quantities of activated
supports (ﬁnal support concentration of 6 g L-1) in sealed glass
Duran® bottles for 48 h on a vibrating shaker at 21∘C. The ﬁn-
ished supports were magnetically retrieved from suspension and
washed copiously with 0.5mol L-1 NaCl and then water before
ﬁnally storing at 4∘C in 20mmol L-1 sodium phosphate, 1mol L-1
NaCl, pH 6.8 until required. The presence of 4-MEP in the ﬁnal
adsorbent preparations was assessed by FTIR.
Feedstock
The rabbit antiserum used in this work is a highly complex feed-
stock containing unusually high levels of immunoglobulin (Ig).5.6
For all small-scale binding studies and determination of adsorbent
loading capacity to use in HGMF, crude rabbit antiserum pools
from ‘Danish Whites’ were ﬁrst ﬁltered free of particulate matter
by passage through a Nalgene disposable dead end membrane
to yield clariﬁed undiluted sera hereafter designated ‘100% serum
strength (the mean Ig and total protein concentrations in serum
weredeterminedas 25±1.3 g L-1 and93±2 g L-1, respectively, and
the electrical conductivity at 20∘C was 10.8 mS cm-1). This feed-
stock was used in variously diluted forms yielding serum strengths
ranging from 0.04 to 22.5% (v/v). For the recovery of Ig by HGMF,
the crude (unclariﬁed) antiserum was simply diluted tenfold.
J Chem Technol Biotechnol 2018; 93: 1901–1915 © 2018 The Authors. wileyonlinelibrary.com/jctb
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Figure 1. Scheme for the manufacture of the 4-MEP linked magnetic supports used in this study. Key: ai NaOH, rt; aii washing (water → NaCl →
methanol), rt; bi 3-aminopropyltriethoxysilane, glacial acetic acid, methanol, 600 s @ 13 000 rpm→ 2 h @ 6000 rpm, rt; bii glycerol, N2, 11 h @ 110
∘C,
0.5 h @ 160 ∘C; biii washing (water→ NaCl→ water), rt; ci glutaraldehyde, pH 11, 1 h, rt; cii washing (water→ NaCl→ water); d epichlorohydrin, NaOH,
NaBH4, 6 h, rt; e allyl bromide, NaOH, NaBH4, DMSO, 18–20 h, rt; f allyl glycidyl ether, NaOH, NaBH4, DMSO, 18–20 h, rt; g divinylsulphone, Na2CO3, 1 h, rt;
hN-bromosuccinimide, 1 h, rt; j 4-mercaptoethyl pyridine hydrochloride, Na2CO3, NaBH4, 48 h, rt.
Batch binding and elution studies
Small-scale batch binding and elution tests were conducted in
2mL screw-capped vials (Sarstedt, Nümbrecht, Germany) at room
temperature. Supports (1.8–45mg) were magnetically recovered
from storage buﬀer, resuspended and equilibrated in a deﬁned
volume of appropriate binding buﬀer by two cycles of resuspen-
sion and magnetic separation, before portioning into vials. Some
samples were mixed with 1.5mL aliquots of diluted antiserum for
various times at 21∘C on an IKA VXR-S17 vibrating shaker plat-
form (IKA Labortechnik, Staufen, Germany), whereas others were
sacriﬁced for dry weight measurements in order to determine the
exact amounts of support used in each test. After binding, sup-
ports were retrieved on amagnetic rack, washed once brieﬂy (30 s)
with binding buﬀer, before adding elution buﬀer (0.1–1mol L-1
sodium acetate) and incubating for 600 s on a vibrating shaker. In
most cases two sequential elution cycles were performed.
The initial selection of buﬀers for equilibration/washing and
elution was informed by previous work on the chromatography
of human32 and especially rabbit5,6 polyclonal antibodies on MEP
HyperCel.
In preliminary screeningof the variousMEP-linked support types
(I–IV), supports (9–12mg) were equilibrated with 50mmol L-1
Tris–HCl pH 8 and then incubated with 1.5mL of 20% (v/v)
antiserum for 0.5 h. After magnetic separation the supports
were washed with binding buﬀer, before ﬁnally incubating pro-
tein laden adsorbents for 0.5 h with 1.5mL of elution buﬀer
(50mmol L-1 sodium acetate, pH 4).
All subsequent characterisation of binding, washing and elu-
tion operations were conducted with type III supports. Binding
optimisation was performed at 1.5mL scale (using 10% v/v
antiserum feedstocks and 8.5mgmL-1 of supports) by systemat-
ically varying the contact time (20–900 s; 50mmol L-1 Tris–HCl
pH 8), pH (employing 50mmol L-1 sodium citrate pH 6 and 50
Tris–HCl pH 7–9 buﬀer) and doping of binding buﬀer (50mmol L-1
Tris–HCl pH 8) and diluted antiserum with various concentrations
(0–150mmol L-1) of ammoniumsulphateor sodiumchloride. After
identifying the ‘best’ conditions for Ig binding, the adsorption per-
formance of the type III MEP-linked support was characterised
further in two sets of experiments in which various dilutions (4.5-
to 2500-fold) of antiserum were contacted with a ﬁxed concen-
tration of supports (4.6mgmL-1), and 10.2% (v/v) antiserum was
mixedwith support at ﬁnal concentrations of 1.2–30mgmL-1. The
key variable examined in optimisation of washing immediately
post-binding and prior to elution was the support concentration,
whereas for elution, in addition to varying support concentration,
diﬀerent strengths (0.05–1mol L-1) of sodium acetate and citrate
buﬀers and ﬁne tuning of elution pH (between 3.5 and 4.5) were
explored.
Liquid-phase samples from all of the above tests (antiserum
feedstock, unbound, wash and elution fractions) were retained
for determination of residual Ig and total protein contents, and
protein composition. The amounts of bound Ig and total protein
were computed from the diﬀerence in liquid phase concentration
before and after binding, and in some cases adsorption data were
ﬁtted to the Langmuir model33 (Equation (1)):
Q∗ = Qmax
C∗
Kd + C∗
(1)
where Q* and C*, respectively, represent the equilibrium concen-
trations of adsorbed and liquid-phases binding species, Qmax is
the maximum protein binding capacity of the support, and Kd is
the dissociation constant. Data was ﬁtted to the model using the
𝜒2 minimisation procedure of OriginPro 2017 software (OriginLab
Corporation, Northampton, MA, USA).
wileyonlinelibrary.com/jctb © 2018 The Authors. J Chem Technol Biotechnol 2018; 93: 1901–1915
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High-gradient magnetic ﬁshing (HGMF)
Equipment set-up and operation
A schematic illustrationof the laboratory scaleHGMF rig employed
in this work is shown in Fig. 2; the operation of which has been
described in detail by Meyer et al.25 At its core is a 70 kg mini-pilot
scale cyclically operated ‘ON–OFF’ permanent magnet based
high-gradient magnetic separator (HGF-10, Steinert Elektromag-
netbauGmbH, Köln, Germany)with an adjustable air-gapbetween
the poles of 1.5–2.5 cm. In this study, the gap was set to 1.5 cm
and the measured magnetic ﬂux densities in the ‘ON’ and ‘OFF’
positions were, respectively, 0.56 and 0.03 T. A small magnetic
ﬁlter was constructed by inserting a tightly-rolled mat of woven
430 stainless steel mesh (ﬁbre thickness ∼110 μm) into a 4.4mL
plastic canister (56mm long × 10mm i.d) so that it occupied 11%
of the working volume (i.e. voidage= 0.89, void volume= 3.9mL).
The resulting magnetic ﬁlter was then positioned vertically
between the pole shoes (area= 100mm× 80mm). The HGMF set
up comprised: (i) a stirred batch adsorption reactor; (ii) the afore-
mentionedmagnet andmagnetic ﬁlter canister; (iii) two peristaltic
pumps (Masterﬂex L/S Easy-Load model 7518-00, Cole Parmer
Instruments Co., Vernon Hills, IL, USA); and (iv) SuperFrac fraction
collector ﬁtted with high ﬂow adaptors (GE Healthcare, Uppsala,
Sweden). The ﬂow paths for particle loading, washing, protein elu-
tion, and particle recovery were controlled with a set of three-way
solenoid switching valves (Bürkert Werke GmbH Fluid Control
Systems, Ingelﬁngen, Germany). With the ﬁeld switched ‘ON’, the
adsorbent particle/feedstock suspensionwaspumped to themag-
netic ﬁlter through values 1–3 via pump 1. Washing and elution
operationswere conductedwith the aidof a recycle loop (11.6mL).
After ﬁlling the loop via valves 4 and 5, the canister–loop circuit
(available volume= 15.5mL) was closed by switching valves 2 and
3. The ﬁeld was switched ‘OFF’ and the liquid contained within
the closed loop was driven at high speed via pump 2 to release
particles from themagnetic ﬁlter wires. Subsequently the ﬁeldwas
switched back ‘ON’ to recapture themagnetic adsorbent particles,
and after turning valve 3, washed oﬀ or elutedmaterials were sent
to the fraction collector. Finally, support particles were recovered
by switching the ﬁeld ‘OFF’ and pumping out of the system via
pump1. TheHGF-10magnet, pumps andvalveswere all controlled
by National Instruments™ LabVIEW software (Austin, TX, USA).
Determination of ﬁlter capacity
Prior to carrying out HGMF recovery of Ig from unclariﬁed rab-
bit antiserum, the loading capacity of the HGMF ﬁlter for type III
MEP-linkedmagnetic adsorbentswas examined in a breakthrough
study employing clariﬁed 10% (v/v) antiserum containing support
particles at a concentration of 30mgmL-1. With the ﬁeld switched
‘ON’ the suspension was loaded into the magnetised ﬁlter at a lin-
ear ﬂow rate of 24m h-1. Particle breakthrough in the ﬁlter eﬄuent
was monitored by gravimetric measurement of the particle mass
in collected samples.
Recovery of immunoglobulins from unclariﬁed rabbit antiserum
by HGMF
Type III magnetic MEP-linked adsorbents (previously equilibrated
in 50mmol L-1 Tris–HCl, pH 8) were resuspended in crude unclar-
iﬁed rabbit antiserum (diluted in the same buﬀer) to give ﬁnal
particle and antiserum concentrations of 31.7mgmL-1 and 10%
(v/v), respectively, and thereafter mixed at room temperature
with an overhead stirrer for 600 s. Subsequently, with the mag-
net switched ‘ON’, the particle/antiserum suspensionwas pumped
Figure 2. Schematic representation of the HGMF system employed. Key:
batch adsorption reactor (BAR); magnetic ﬁlter (MF); fraction collector (FC);
valves (V1–V5); pumps (P1 & P2); wash buﬀer (WB); elution buﬀer (EB).
upward through themagnetic ﬁlter at a linear ﬂow rate of 24m h-1.
Pumping was stopped before breakthrough was expected, i.e.
after 11.5mL of suspension containing 365mg particles had been
loaded into the magnetised ﬁlter. The recycle loop (11.6mL) was
then ﬁlled with washing buﬀer (50mmol L-1 Tris–HCl, pH 8) and
after turning the ﬁeld ‘OFF’, the suspension was pumped around
the recycle loop upwards with respect to the magnetic ﬁlter at a
velocity of 92m h-1 for 60 s, to wash out entrained and/or loosely
adsorbed materials. The particles were subsequently recaptured
by switching the ﬁeld back ‘ON’, the ﬂow rate was lowered to
24m h-1 and the washings were pumped out of the rig to the
fraction collector. Bound Ig and protein was desorbed from the
retained MEP-linked adsorbent particles in 600 s elution cycles in
exactly the manner just described for washing, i.e. by ﬁlling the
recycle loop with elution buﬀer (0.5mol L-1 sodium acetate, pH 4),
and rapidly circulating theparticles around the closed system loop.
The volumes of all collected fractions were accurately measured
and all fractions were analysed for immunoglobulin and total pro-
tein contents, and composition by SDS-PAGE.
Analytical techniques
Thin-layer chromatography was performed on Merck Silica gel
60 F254 plates and spots were visualised under ultra-violet light.
1H and 13C NMR spectra were recorded at 500 and 125.7MHz,
respectively, on a Varian Inova 500 spectrometer.
For qualitative FT-IR analysis of solid supports, 2mg samples pre-
viously dried in a desiccator were mixed with 298mg potassium
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bromide, ground down to a ﬁne powder and hydraulically pressed
(15 tonnes) into tablet form. Each tablet was subjected to 64 scans
(averaged at a resolution of 2 cm−1) in a Nicolet 380 FT-IR (Thermo
FisherScientiﬁc, Waltham, MA, USA) in direct beammode.
Magnetic particle content was determined using a dry weight
method based on that described by Hubbuch and Thomas.20 Bulk
magnetic properties were investigated at ambient temperature
in a MicroMag™ 2900 Alternating Gradient Magnetometer (PMC,
Princeton, NJ, USA) and particle size analysis was performed with
a Mastersizer2000 particle size analyser (Malvern Instruments Ltd,
Malvern UK).
The concentration of antibodies in bulk phase samples was
determined using a robust high throughput immunoturbidimetric
assay advanced by Bak and co-workers.34 The method, based on
the scattering of light caused by the formation of diﬀerent sizes of
immune complexes by diﬀerent ratios of antibody to antigen, was
speciﬁcally developed for in-process determination of polyclonal
antibody concentration in crude samples, and has been shown
to be insensitive to all of the equilibration/binding/wash and
elution buﬀer combinations employed in this work. The original
96-well plate procedurewas adapted so that it could beperformed
automatically in a spectrometric robot system (Cobas Mira Plus
Random Access Analyser, Roche Diagnostic Systems, Rotkreutz,
Switzerland) as follows: Samples (35 μL) weremixed with 126 μL of
reaction buﬀer and incubated at 37 ∘C. After 300 s, the absorbance
was recorded at 340 nm and 84 μL of twofold diluted GoaRbIg
was added. After 300 s incubation at 35 ∘C, the absorbance was
again recorded at 340 nm. Standards of puriﬁed immunoglobulins
from non-immunised rabbits, prepared in dilution buﬀer to a ﬁnal
concentration ranging from 6.6 to 500 μg mL-1, were treated in
exactly the same way as the samples.
The total protein contents of liquid phase samples were deter-
mined by the BCA protein assay (Pierce Rockford, IL, USA) adapted
for use in the Cobas Mira Analyser. All results are expressed in mg
bovine serum albumin (BSA) equivalents. Corrections for variation
in Ig content in samples were not applied. In the assay the A0.1%562nm
rabbit IgG: A0.1%562nm BSA ratio= 1.12; thus calculated ﬁgures for Ig
purity, puriﬁcation and yield factors, in this work, are underesti-
mated.
Protein composition was analysed by reducing SDS-PAGE35 in
NuPAGE® Novex Bis-Tris (4–12%) gels. Images of gels were cap-
tured using a GelDoc2000 system (Bio-Rad Laboratories, Hercules,
CA, USA) and the relative densities of stained bands in destained
gels were analysed using ImageJ software, downloaded from
http://rsb.infonih.gov.ij/.
The RSA contents in eluates are expressed as percentages of
the Ig signal by dividing the RSA band intensity in each lane by
the combined Ig heavy and light chain band intensities, and then
multiplying by 100.
RESULTS ANDDISCUSSION
Magnetic support design
Gu and coworkers36 recently demonstrated eﬀective use of
magnetic agarose based adsorbents derivatised with the
hydrophobic-charge induction ligand, 5-aminobenzimidazole,
for antibody capture from a dilute mimetic serum (IgG+ BSA),
mimetic serum ‘spiked’ with yeast cells, and CHO culture
supernatant. The much more complex, concentrated and foul-
ing antiserum feeds used in this work dictated choice of a less
‘challenged’ adsorbent design. Much previous work conﬁrms that
sub-micron sized non-porous magnetic adsorbents fashioned
from thePG-coated superparamagnetic baseparticle describedby
Hubbuch and Thomas20 are well suited for operation in unclariﬁed
and heavily fouling bioprocess liquors.18,22–25,30 It is rarely appreci-
ated that non-porous supports are less prone to fouling and easier
to clean once fouled, than their porous counterparts,37,38 and are
therefore inherently more useful for product capture and puriﬁ-
cation from fouling liquors.15 For porous supports, intra-particle
pore fouling is an especially serious issue. Foulants ingressing into
and trapped within pores are more diﬃcult to dislodge that those
adhering to the external surface; this is largely because internal
pores are eﬀectively isolated from the eﬀects of external ﬂuid
shear cf. the external surface.37,38
Screening of MEP-linked adsorbents prepared via diﬀerent
activation routes
Four diﬀerent activation chemistrieswere employed on PG-coated
magnetic particles prior to coupling MEP (Fig. 1). FT-IR analysis
conﬁrmed successful installation of 4-MEP in all cases. The spectra
of ﬁnished adsorbents contained absorbance peaks at ∼804 cm-1
and∼1599 cm-1 corresponding to the thioether bond (-C-S-C-) and
imine, respectively, whereas those of controls (i.e. activated sup-
ports subjected in parallel to the same coupling conditions, but
without 4-mercaptoethylpyridine) showed no such peaks. Table 1
shows the results of initial matrix scouting performedwith the var-
ious MEP-linked supports (I–IV) at a concentration of 7mgmL-1 in
20% (v/v) clariﬁed rabbit antiserum representing an eﬀective chal-
lenge of 28.6mL of undiluted ‘100%’ serum per g support. Under
these conditions, between 5.6 and 25.4% of the available Ig and
9.1 to 19.8% of the total soluble protein was removed from anti-
serum. Only two of the four supports bound Ig selectively over
total protein, i.e. types I and III. Though the highest Ig binding
(181mgg-1) was demonstrated by the type I support prepared by
ECH activation routewith puriﬁcation, the type III support (Ig bind-
ing capacity= 170mgg-1), produced via two-step AGE activation
andbrominationprocedure, demonstrated substantially greater Ig
binding selectivity. The purity on adsorption was >56% (cf. 34.4%
for type I) reﬂecting a puriﬁcation adsorption (PFads) of 2.1 (cf.<1.3
for type I). Surprisingly, type II and IV supports displayed greater
preference for the binding of non-Ig proteins reﬂected by lower
purity of Ig in the adsorbed state, i.e. 11.5% and 18.5% for types
II and IV respectively cf. that of the initial antiserum (26.9%). In all
cases, the wash step, conducted immediately post-binding, des-
orbed large amounts of entrained and weakly adsorbed protein,
such that signiﬁcant enhancements in adsorbed Ig purity were
achieved prior to elution. For example, in the best case (type III
supports) 46% of the adsorbed total protein was desorbed at the
expense of a 14% loss in bound Ig such that the purity rose to 89%.
In the subsequent pH elution step, Ig was preferentially eluted
over other adsorbed proteins from all supports (Table 1). A palpa-
ble trend, supported by electrophoretic analysis (Fig. 3), is that the
greater the selectivity displayedby the support (type III> I> IV> II)
during the binding step, the higher the Ig purity of the ﬁnal eluate
(95% for type III, 92% for type I, 83% for type IV and 64% for type II).
All eluates contained rabbit serum albumin (RSA), the main impu-
rity in serum, but the levels of RSA contamination variedmarkedly.
Whereas strong RSA bands are evident in lanes corresponding to
eluates from type IV and II supports, they are barely discernible in
the eluates from the type I and III adsorbents.With the aid of Image
J analysis, the signal intensities for RSA expressed as percentages
of the combined Ig band intensities in each lane were determined
as 2, 4, 13 and 41% for the eluates from support types III, I, IV and
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Table 1. Comparison of MEP linked support types I – IV (see Fig. 1) for the recovery of immunoglobulins from 20% (v/v) clariﬁed rabbit antiserum
(see text for details)
Binding Elution
Support ID
Activation
method
Ig bound
(%)
Total protein
bound (%)
Q*Ig
(mgg-1)
Q*Total protein
(mgg-1)
Adsorbed Ig
purity (%) PFads*
Ig yield
(%)
Ig
purity (%) PF**
Type I ECH 25.4 19.8 181 527 34.35 1.28 12.55 91.7 3.41
Type II AB 5.6 13.1 40 347 11.53 0.43 2.93 63.9 2.38
Type III AGE 23.8 11.4 170 303 56.11 2.09 13.7 95.0 3.53
Type IV DVS 12.5 18.1 89 480 18.54 0.69 10.82 83.3 3.10
*PFads =puriﬁcation factor for the adsorption step and **PF= overall puriﬁcation factor.
Figure3.Reducing SDS-PAGE analysis of eluates fromMEP-linked supports
obtained during Ig recovery from clariﬁed rabbit antiserum. Key:molecular
weight markers (M); rabbit antiserum (1); eluates fromMEP support types I
(2), II (3), III (4) and IV (5); RSA= rabbit serumalbumin; Ig= immunoglobulin;
HC=heavy chain; LC= light chain.
II, respectively. The type III adsorbent prepared by the AGE acti-
vation route was selected for use in all further studies in view of
its superior overall performance. Nearly 14% of the Ig present in
the antiserum was recovered with a purity of 95% representing a
puriﬁcation of >3.5-fold.
Though neither the extent of activation nor MEP ligand den-
sity were measured in this work, the diﬀerences in Ig binding and
puriﬁcation performance noted here (Table 1 and Fig. 3) for the
various MEP-linked magnetic adsorbents likely stem from a com-
plex interplay of spacer chemistry (Fig. 1) and immobilised ligand
density. Boschetti39 stressed: (i) the potential beneﬁts of including
a sulphur atom in the spacer (applicable in the case of the type
IV support prepared via DVS activation, see Fig. 1); (ii) the impor-
tance of employing suﬃciently hydrophobic spacer arms; and cru-
cially (iii) that IgG adsorption is strongly dependent on the density
of hydrophobic MEP ligands anchored to the support’s surface.
Adsorption can only occurwhen a certain critical hydrophobicity40
is reached (in the case of MEP HyperCel Boschetti39 states this
is >40mmolmL-1); beyond this point binding capacity increases
until saturation. The superior performanceof the type III adsorbent
over other types in this work likely reﬂects that it represents the
best ‘ligand density/spacer hydrophobicity’ combination.
Optimisation of binding conditions
Figure 4 shows the results of systematic experiments aimed at
identifying eﬀective binding conditions for selective recovery of
immunoglobulins from clariﬁed 10% (w/w) rabbit antiserumusing
type III non-porous magnetic MEP-linked adsorbents at support
concentration of 8.5mgmL-1 (challenge= 11.8mL equivalents of
100% serum per g support).
Kinetics
The kinetics of Ig and protein binding are presented in Fig. 4(a). As
has been noted before with other adsorbents fabricated from the
same submicron sized and essentially non-porous magnetic base
matrix, binding equilibrium is attained very rapidly;22,25,26,30,41,42 in
the present case by the ﬁrst time point, i.e. 45 s, which represents
theminimum time required for handling samples on themagnetic
rack. No diﬀerence in binding kinetics for Ig and total protein was
observed in the experiment, thus the adsorbed Ig purity remained
constant averaging 55.34± 2.38% over 10 time points between 45
and 900 s. For purely practical reasons, a binding time of 600 s was
adopted in all subsequent work.
pH
Varying the pH of the binding buﬀer used for support equili-
bration and dilution of the antiserum exerted a strong impact
on both the amount and selectivity of Ig binding by the adsor-
bent (Fig. 4(b)). Maximum Ig binding (46.7% of that presented)
and selectivity of adsorption (PFads = 2.07–2.14 corresponding to
a purity on adsorption of 57.5%) were obtained at a pH of 8,
and substantial retention of binding selectivity was maintained
between pH7 and 9. However, shifting to lower pH values seri-
ously compromised both the level and selectivity of Ig binding.
For example, at pH 6< 16% of the available Ig was adsorbed and
all binding selectivity was lost (calculated Ig purity of 26.6% is less
than that of the initial antiserum). The pH dependence of rabbit
Ig adsorption on type III MEP-magnetic adsorbents observed here
accords with earlier studies conductedwith human polyclonal IgG
and MEP HyperCel, and is consistent with the 4-MEP ligand’s pKa
of 4.8 and the pH-dependent adsorption–desorption mechanism
described by Burton and Harding31 and corroborated by Boschetti
and colleagues,32,39 i.e. hydrophobic interaction under near physi-
ological conditions in the absence of a lyotropic salt, and desorp-
tion via pH induced electrostatic charge repulsion.
Inﬂuence of salt concentration
Guerrier et al.32 previously reported that polyclonal human IgG
binding to MEP HyperCel is salt-independent up to an electrical
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Figure 4. Optimisation of conditions (a – time, b – pH, c – conductivity)
for the binding of rabbit Ig from clariﬁed 10% (v/v) antiserum on type
III MEP-linked magnetic adsorbent particles (ﬁxed support concentra-
tion= 8.5mgmL-1). Key: percentage bound Ig (white squares); percentage
bound protein (black squares); percentage Purityads (grey up-triangles).
The largeand small symbols used inplot c are for dataobtainedwith ‘added
NH4(SO4)2’ and ‘added NaCl’ respectively.
conductivity of 100 mS cm-1 (the authors employed 25mmol L-1
sodium phosphate pH 7 variously supplemented with up to
1mol L-1 NaCl). Boschetti39 later conﬁrmed no diﬀerence in the
binding of human polyclonal antibodies to MEP HyperCel in
the absence and presence of added sodium chloride, but that the
addition of ammonium sulphate conveyed higher binding capaci-
ties consistentwith thiophilic adsorptionwhich is enhancedby the
presence of lyotropic salts.43 Diﬀerent behaviour is exhibited by
the type III MEP-linked adsorbent and rabbit antibodies employed
here. Antiserum was diluted tenfold with 50mmol L-1 Tris–HCl
pH 8 buﬀers supplemented with ammonium sulphate (lyotropic)
or sodium chloride (chaotropic) at various concentrations up to
Figure 5. Eﬀect of varying (a) antiserum strength (ﬁxed support concen-
tration= 4.6mgmL-1) and (b) support concentration (ﬁxed 10.2% v/v anti-
serum feed) on Ig and total protein binding of type III MEP-linkedmagnetic
adsorbents. Key: percentage bound Ig (white squares); percentage bound
total protein (black squares); Ig binding capacity (white circles); total pro-
tein binding capacity (black circles).
150mmol L-1 and contacted with adsorbents previously equili-
brated in the same buﬀer. Figure 4(c) shows ammonium sulphate
and sodium chloride data series – for percentage bound Ig and
total protein and percentage purity in the adsorbed state vs con-
ductivity – collapsing along common curves, and that increasing
conductivity compromises both the level and selectivity of Ig
adsorption signiﬁcantly. For example, addition of 0.15mol L-1
ammonium sulphate to the clariﬁed rabbit antiserum feedstock
(which raised the electrical conductivity at 20∘C from 5.6 to
31.5 mS cm-1) led to >40% reduction in binding coupled with a
drop in adsorbed purity from 57.5 to <45%. The salt dependent
binding observed here for rabbit Ig from antiserum on MEP may
in part reﬂect rabbit IgG’s (the dominant species in the feed-
stock) observed tendency to dimerise as salt concentration is
increased.44,45 A reduction in Ig binding with increasing levels of
salt induced dimer is consistent with the observation of reduced
binding capacities for larger Ig isotypes, e.g. IgA.39 However,
in a recent study with pure hIgG and MEP HyperCel, Yuan and
coworkers46 noted similar binding trends at low concentrations
of NaCl and (NH4)2SO4, i.e. steady reductions in binding capacity
with increasing concentration, reachingminima at 250mmol L-1 of
both salts; followed by increased binding with further addition of
salt. Yuan et al.46 examined this complex behaviour using isother-
mal titration calorimetry, revealing that the addition of low levels
of salt (0–0.25mol L-1) weakened hydrophobic interactions (caus-
ing entropy change) and strengthened van der Waals, H-bonding
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and ionic interactions which led to negative enthalpy change,
whereas higher concentrations (0.25–0.75mol L-1) resulted in
increased hydrophobic and diminished electrostatic interactions.
Characterisation of binding performance of type III
MEP-linked adsorbent for use in HGMF
Antiserum/support ratio
The most important parameter aﬀecting the performance of any
HGMFprocess is themagnetic adsorbent’s selectivity for the target
product in the feedstock fromwhich it is to be recovered. Eﬀective
conditions for the capture of rabbit polyclonal Ig from tenfold
diluted antiserum established, (i.e. adsorption time of 600 s,
support equilibration and feedstock dilution with 50mmol L-1
Tris–HCl pH 8), it was subsequently necessary to further probe
the equilibrium state developed within the adsorption vessel
by systematically mapping the impact of antiserum/support
ratio (speciﬁcally mL equivalents of 100% serum per g of sup-
port) on the immunoglobulin yield and purity achieved in the
adsorption step. This was done in two ways. In the ﬁrst cycle of
experiments, a ﬁxed concentration of type III MEP-linked mag-
netic adsorbents 4.6mg per mL of feedstock) was contacted with
2500–∼4.5-fold diluted rabbit antiserum (Fig. 5(a)), representing
antiserum/support ratios ranging from 0.08 – ∼49mL equivalents
of 100% antiserum per g support. In the second experimental
series (Fig. 5(b)), ﬁxed volumes of 10.2% (v/v) antiserum were
mixed with various concentrations of the same support (ﬁnal con-
centrations of 1.2–30mg per mL of feedstock) to give a narrower,
but more densely populated window of ‘antiserum/support’
challenges (3.4 to ∼85mL equivalent to 100% antiserum per g
support). The inﬂuence of antiserum/support ratio on the binding
performance of type III MEP-linked adsorbents (transposed from
the data in Fig. 5(a) and (b)) is illustrated in Fig. 6. Essentially
complete Ig adsorption required antiserum/support ratios <1mL
equivalent to 100% antiserum per of support (Fig. 6(a)). However,
at such low antiserum/support challenges, the operational Ig
binding capacity is very low (<30mgg-1) and co-adsorption of
non-Ig proteins unacceptably high (>60% of the total protein
supplied) such that the purity of the adsorbed Ig is 40% or less,
corresponding with puriﬁcation factors on adsorption, PFads,
of <1.5. The Ig binding capacity of the type III adsorbent rose
strongly as the antiserum/support ratio was increased, reaching
140 and 200mgg-1 at values of 10 and 50mL equivalent to 100%
antiserum per g support, respectively, albeit at the expense of
marked losses in adsorbed Ig yield (Fig. 6(a)). The total protein
binding capacity of the adsorbent increased in similar manner,
rising from<70mgg-1 at 1mL equivalent to 100% antiserumper g
support to 240mgg-1 at 10mL equivalent to 100% antiserum and
on past 350mgg-1 at 50mL equivalent to 100% antiserum per g
support, a value indicative from past experience with adsorbents
fashioned out of the polyglutaraldehyde-coated magnetic base
particle employed here of multi-layer binding.23
The degree of puriﬁcation achieved on adsorption (PFads) was
observed to rise as antiserum/support ratio was raised, reaching
a maximum value >2 at 20mL, equivalent to 100% antiserum per
g support, and thereafter declining slightly with further increase
in antiserum/support ratio in keeping with the aforementioned
transition frommono- to multi-layer protein binding.
Identifying the correct amount of magnetic adsorbent to treat
a given volume and strength of feedstock is an especially impor-
tant design consideration for an HGMF process.18,19 A favourable
operating point may be deﬁned mathematically by the yield fac-
tor, i.e. the product of the puriﬁcation factor and fractional yield of
Figure 6. Impact of antiserum/support ratio on the binding performance
of type III MEP-linked adsorbents. Key: (a) percentage bound Ig (white
squares), percentagebound total protein (black squares), Ig binding capac-
ity (white squares), total protein binding capacity (black squares); (b) frac-
tional Ig yield (solid line), puriﬁcation factor on adsorption (PFads, dashed
line), yield factor on adsorption (YFads, dotted line).
the target species.18,25 In the present case the maximum yield fac-
tor on adsorption, YFads, occurs at an antiserum/support challenge
of ∼3mL equivalent to 100% antiserum per g support (Fig. 6(b)).
Practically, this corresponds to treatment of a 10% (v/v) anti-
serum feedstock with type III support at a ﬁnal particle concen-
tration of 25–30mgmL-1. Under these conditions, >90% of the Ig
present in the antiserum is adsorbed in a 1.9-fold puriﬁed state
(Purityads = 53%) at a working capacity of >80mgg-1.
Bak5 previously reported that the adsorption of rabbit antibod-
ies to MEP HyperCel is weaker than that of human IgG and that
dynamic binding capacities were roughly half those of human IgG.
Despite this, and the abundance of non-Ig proteins in rabbit anti-
serumesp. RSA,measurements of free Ig content in 4.5- to 833-fold
diluted antiserum feedstocks remaining after 0.25 h of contact
conﬁrmed strong (Kd < 0.1mgmL
-1 ≈ 0.5 μmol L-1) high capacity
(Qmax = 214mgg-1) adsorption from the feedstock (Fig. 7(a)). Mea-
surements of free total protein on the other hand produced a dif-
ferently shaped binding curve, namely initially favourable rising
towards a plateau around 200mgg-1, but then curving strongly
upwards (indicative of multi-layer binding) as the concentration
of antiserum supplied is increased.23 The non-selective binding
nature of the MEP ligand, well documented in the case for MEP
HyperCel,6,39 is also noted for themagneticMEP-linked adsorbents
employed herein.
Despite favourable adsorption of the target Ig, substantial
non-speciﬁc protein binding is observed at all antiserum/support
challenges (Fig. 6). That this binding is weak is highlighted by
the observation in Fig. 7(b) that a single rapid 30 s washing step
employing the binding/dilution buﬀer dislodges much of the
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Figure 7. (a) Equilibrium adsorption of Ig (white circles) and total pro-
tein (black circles) from clariﬁed rabbit antiserum on type III MEP-linked
magnetic particles. (b) Protein desorbed by washing post-binding (grey
circles) as a function of total protein binding capacity (Q*Total Protein). The
broken line through Ig data in (a) represents the ﬁt of the Langmuir
model (Equation (1)) with the parameters Qmax = 213.7± 18.7mgg-1 and
Kd = 0.085± 0.04mgmL-1.
adsorbed protein resulting in substantial increases in purity
of adsorbed Ig prior to elution albeit at the expense of small
drops in Ig yield (see later, Tables 2 and 3). Beyond Q*Total Protein
∼100mgmL-1, the amount of adsorbed protein removed by
washing rises strongly as Q*Total Protein is raised, reaching ∼58% at
the highest loading (i.e. 215 of the 373mg adsorbed per gram).
Attempts to reduce the level of non-speciﬁc binding by adding
sodium caprylate (an albumin-selective moiety) to the antiserum
feedstock prior to binding and/or the use of sodium caprylate
wash post-binding39,47 were not undertaken to avoid adding
‘another layer of complexity to the puriﬁcation process’.12 Washing
with distilled water prior to elution has been reported as a means
of selectively eluting non-speciﬁcally adsorbed albumin fromMEP
HyperCel,32,39 but was avoided in this work in view of Bak’s5 obser-
vation that the water wash desorbs rabbit immunoglobulins more
readily fromMEP HyperCel columns than bound RSA.
Adsorbent collection by HGMS
Before selecting conditions for elution in HGMF, it was necessary
to establish the likely particle concentration under which wash-
ing and elution could be permitted by the present HGMF system.
This involved deﬁning the capacity of the magnetic ﬁlter for type
III adsorbent particles from 10% (v/v) antiserum under process-
ing conditions (support concentration= 30mgmL-1, B= 0.56 T,
v= 24m h-1) and subsequently calculating the likely adsorbent
concentration within the magnetic ﬁlter canister and associated
recycle loop during washing and elution. 5% particle break-
through occurred after the application of 430mg of type III sup-
port into themagnetised ﬁlter, corresponding to a particle holding
capacity of 97.7 g L-1 based on the total volume of the ﬁlter. The
combined volume of the recycle loop (11.6mL) and ﬁlter cartridge
(4.4mL) minus the 430 stainless steel matrix (0.5mL) in which des-
orption occurs, is 15.5mL. Thus, assuming the support is applied at
75–90%of themagnetic ﬁlter’s 5%breakthroughcapacity the sup-
port concentration during desorption within the HGMF apparatus
would be 20–25mgmL-1. Accordingly, a target concentration of
∼20mgmL-1 of protein loaded adsorbents was selected for opti-
misation of elution conditions.
Optimisation of elution conditions for HGMF
In preliminary tests, varying the pH of the 50mmol L-1 acetate
buﬀer, by± 0.5 units from the initial value of 4 employed in screen-
ing the diﬀerent MEP-linked supports, gave no improvement in
desorption eﬃciency from washed protein-laden supports, and
neither did the use of 100mmol L-1 sodium citrate buﬀers pH 3
and 3.5. We therefore evaluated the strength of acetate buﬀer
needed to confer the necessary driving force for Ig release (Fig. 8).
For this, type III magnetic MEP-linked adsorbent particles were
contacted with 10% (v/v) antiserum at a ﬁnal support concentra-
tion of 24.6mgmL-1 in tenfold diluted serum, washed once with
binding buﬀer at a support concentration of 19.5mgmL-1 and
then mixed at the same concentration with 50mmol L-1 –1mol L-1
sodium acetate buﬀers, pH 4. Immediately post-binding the purity
of adsorbed Ig registered 52%. Following washing, the adsorbed
purity increased to nearly 60% at the expense of a 10% loss in yield
(indicated in Fig. 8(a) by data point at 0mol L-1 sodium acetate). At
the lowest sodium acetate concentrations of 0.05 and 0.1mol L-1
the ﬁrst elution step selectivity of immunoglobulin elution was
high (the purity of desorbed Ig was >93% by assay), however
the recoveries were poor (<20% and< 40% for the 0.05 and
0.1mol L-1 sodium acetate elution buﬀers, respectively). RSA, the
major impurity, is barely visible on reducing SDS-polyacrylamide
gels, representing just 2% of the combined Ig heavy and light
chain intensities (Fig. 8(b)). Desorption yield increases as the elu-
tionbuﬀer strength is raised, but comes at the expense of impaired
selectivity, emphasised by a roughly linear decline in purity by
assay (Fig. 8(a)) and corresponding growth in RSA contamination
(reaching >25% of the Ig signal at 1mol L-1 sodium acetate) and
of higher molecular weight species (Fig. 8(b)). Although a single
elution step employing 1mol L-1 sodium acetate desorbs 91% of
the initially adsorbed Ig, all selectivity is lost (Fig. 8(a), compare
percentage purities at 0 and 1mol L-1 sodium acetate). A further
issue encountered with elution using 1mol L-1 sodium acetate
elution buﬀer, but not the lower concentrations employed, was
the formation of a clear precipitate (most likely of lipoprotein4–6)
after freezing and thawing the eluates. For these reasons, a sodium
acetate buﬀer concentration of 0.5mol L-1 was selected for use in
subsequent HGMF and small-scale puriﬁcation tests, as the best
compromise of yield and purity.
Recovery of Ig from rabbit antiserum feedstocks
Magnetic rack based Ig puriﬁcation from clariﬁed feed
Before conductingHGMFat larger scale, smallmagnetic rackbased
puriﬁcationswereperformed to further examine theeﬀects of sup-
port concentration during washing and elution on Ig puriﬁcation
performance. Two sets of conditionswere employed, i.e. condition
‘A’ – binding andwashing at support concentration of 30mgmL-1
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Table 2. Summary of data for magnetic rack based recovery of Ig from clariﬁed rabbit antiserum (10% v/v) using type III MEP-linked magnetic
adsorbents. Two sets of conditions (A and B) were investigated
Condition A. Support concentration of 30mgmL-1 during binding and washing and 60mgmL-1 during elution
Recovery step Ig (mg) Protein (mg) Purity (%) Ig yield (%) Protein yield (%) PF (-)* YF (-)**
Antiserum 3.95 14.19 27.8 100 100 1.0 1.0
Unbound 0.27 6.93 3.9 6.8 48.8
Bound 3.68 7.26 50.6 93.2 51.2 1.82 1.70
Wash 0.10 1.00 10.0 2.5 7.0
Elution 1 1.68 2.27 73.7 42.5 16.0 2.65
Elution 2 0.94 1.24 75.8 23.9 8.8 2.73
Combined elutions 2.62 3.52 74.4 66.4 24.8 2.68 1.78
Mass balance (%) 75.7 80.7
Elution eﬃciency (%) 73.2 56.2 -
Condition B. Support concentration of 24.6mgmL-1 during binding and 19.5mgmL-1 during washing and elution
Recovery step Ig (mg) Protein (mg) Purity (%) Ig yield (%) Protein yield (%) PF (-)* YF (-)**
Antiserum 3.95 14.19 27.8 100 100 1.0 1.0
Unbound 0.39 7.38 5.3 9.9 52.0
Bound 3.56 6.81 52.2 90.1 48.0 1.88 1.69
Washes 0.13 0.98 13.6 3.4 6.9
Elution 1 2.57 3.44 74.9 65.2 24.2 2.68
Elution 2 0.58 0.77 75.0 14.7 5.4 2.70
Combined elutions 3.15 4.21 74.9 79.9 29.6 2.68 2.14
Mass balance (%) 93.3 88.6
Elution eﬃciency (%) 92.1 72.2
*PF= overall puriﬁcation factor and ** YF= yield factor.
Table 3. Summary of data for HGMF based recovery of Ig fromunclariﬁed rabbit antiserum (10% v/v) using type III MEP-linkedmagnetic adsorbents.
The concentration of support particles employed during binding was 31.7mgmL-1 during binding and 23.5mgmL-1 during washing and elution
Recovery step Ig (mg) Protein (mg) Purity (%) Ig yield (%) Protein yield (%) PF (-)* YF (-)**
Antiserum 28.7 107.6 26.67 100 100 1.0 1.0
Flow through (unbound) 1.35 43.52 3.10 4.7 40.4
Bound 27.35 64.08 42.7 95.3 59.6 1.60 1.52
Wash 1.35 8.29 16.3 4.7 7.7
Elution 1 15.40 19.01 81.0 53.6 17.7 3.04
Elution 2 5.38 6.70 80.3 18.7 6.2 3.01
Combined elutions 20.78 25.71 80.8 72.4 23.9 3.03 2.19
Mass balance (%) 81.8 72.0
Elution eﬃciency (%) 79.9 46.1
*PF= overall puriﬁcation factor and ** YF= yield factor.
and elution at 60mgmL-1; and condition ‘B’ – binding at a sup-
port concentration of 24.6mgmL-1 and washing and elution at
19.5mgmL-1. Table 2 summarises the data obtained and Fig. 9
shows the electrophoretic analysis corresponding to condition B.
In keepingwith earlier ﬁndings (Figs 5 and 6), the higher support
concentration during condition A’s binding step resulted in higher
Ig binding yield (93.2% of that initially present in the antiserum),
but lower purity in the adsorbed state (50.6%) cf. condition B
(90.1% bound, Purityads = 52.2%). The use of a higher support
concentration (condition A) during washing also improved the
selectivity of this step. While very similar amounts of total protein
were desorbed in both conditions, the amount of bound Ig lost
from the supports was >30% lower for condition A (Table 2).
Scrutiny of the electrophoretogram (Fig. 9, lane 3) for condition B
conﬁrms that most of the protein washed from the supports was
RSA; only a faint trace of Ig is visible. Immediately prior to elution,
the Ig yield and purity combinations were little diﬀerent for the
two conditions, emphasised by the similarity in puriﬁcation and
yield factors at this stage of ∼1.85 and ∼2.1 for conditions A and
B, respectively (Table 2).
Thebiggest impact onpuriﬁcationperformancewas the support
concentration used during elution. For condition B (19.5mgmL-1)
two successive elution cycles recovered >92% of the Ig remaining
bound on supports after washing, leading to an overall Ig recovery
of∼80%.Calculateddesorptioneﬃciencies for theﬁrst and second
cycles were similarly high (i.e.>75% in the ﬁrst, dropping to>68%
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Figure 8. Eﬀect of sodium acetate pH 4 buﬀer concentration on the (a) desorption of bound rabbit Ig and total protein from washed type III MEP-linked
magnetic adsorbents in a single elution cycle and (b) corresponding SDS-PAGE analysis. The support concentration during binding was 24.6mgmL-1 and
was reduced to 19.5mgmL-1 for washing and elution. The amounts of Ig and total protein released are expressed as percentages of the total bound prior
to elution. Key: desorbed Ig (white up-triangles), desorbed protein (black up-triangles); Ig purity (grey up-triangles).
Figure 9. Reducing SDS-PAGE analysis of ‘Table 2 Condition B’ samples
arising frommagnetic rack based Ig recovery fromclariﬁed 10% (v/v) rabbit
antiserum using type III MEP-linked magnetic supports. Key: molecular
weight markers (M); rabbit antiserum (1); unbound (2); wash (3); elution
1 (4); elution 2 (5); RSA= rabbit serum albumin; Ig= immunoglobulin;
HC=heavy chain; LC= light chain.
in the second). Desorption eﬃciency was markedly reduced when
a more than threefold higher support concentration (60mgmL-1)
was employed (condition A), falling to 46.9 and 49.7% in the
ﬁrst and second cycles, respectively. As a result the overall yield
registered 66.4%, but the purity was not aﬀected (Table 2).
HGMF based Ig puriﬁcation from unclariﬁed feed
The limited availability of feedstock constrained the scale at which
HGMF could bedemonstrated and the type of device that could be
used, and permitted only a single run to be conducted. The results
from small-scale magnetic rack studies (Table 2) were thus crucial
in informing selectionof conditions forHGMF fromunclariﬁed10%
(v/v) antiserum. The support concentration during binding was
increased to 31.7mgmL-1 (cf. 24.6 and 30mgmL-1 for conditions
B and A, respectively; Table 2), and the adsorbent concentration
Figure 10. Reducing SDS-PAGE analysis of ‘Table 3’ samples arising from
HGMF based Ig recovery from unclariﬁed 10% (v/v) rabbit antiserum using
type III MEP-linkedmagnetic supports. Key: molecular weight markers (M);
rabbit antiserum (1); ﬂow through (2); wash (3); elution 1 (4); elution 2
(5); RSA= rabbit serum albumin; Ig= immunoglobulin; HC=heavy chain;
LC= light chain.
during the wash and elution steps was 23.5mgmL-1. The same
binding and elution times were employed (i.e. 600 s in both cases),
but given the presence of solids in the unclariﬁed antiserum feed
and to ensure eﬃcient particle release from the magnetic ﬁlter,
the duration of the single wash cycle was raised from 30 to 60 s.
Table 3 summarises the results obtained and Fig. 10 displays the
corresponding SDS-PAGE analysis of fractions from the run.
In general, it is clear that puriﬁcation transferred successfully
from magnetic rack (Table 2) to HGMF operation (Table 3) and
that the added presence of suspended solids in the unclariﬁed
antiserum did not perturb overall Ig puriﬁcation performance, as
the combined yield of >72% from two elution cycles was similar
and the calculated Ig purity of 81% was slightly higher than
that achieved in smaller scale tests with the clariﬁed antiserum
feedstock. Closer scrutiny of the data obtained at each sub-step
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however, highlights diﬀerences arising from the feedstock (i.e.
unclariﬁed vs clariﬁed) and/or magnetic particle separation mode
(i.e. magnetic ﬁlter vs magnetic rack) employed.
The slightly higher support concentration employed during
binding resulted in capture of >95% of the Ig from the unclari-
ﬁed antiserum (Table 3); but this small gain was oﬀset by a larger
increase in the amount of protein adsorbed onto the supports (i.e.
to nearly 60% cf. 51–52%), thus the calculated purity in adsorbed
state prior to washing was just 43% cf. 51–52% observed in the
smaller scalemagnetic rack experiments conductedwith the clari-
ﬁed feed (Table 2). After washing, the amount of protein adsorbed
on the support dropped signiﬁcantly (to 52%), but not to the level
expected from smaller scale magnetic rack conducted with clari-
ﬁed antiserum (i.e. 41–44%), while the amount of adsorbed Ig lost
into the wash increased to 4.7% (Table 3). Both eﬀects probably
stem from ‘additional’ surface fouling from extra components in
suspended solids in unclariﬁed feed. The selectivity of Ig desorp-
tion from supports during elution in HGMFwas not aﬀected by the
increased level of competing species adsorbed on the non-porous
surfaces of themagneticMEP-linked adsorbent particles (compare
entries for percentage eluted of ﬁrmly bound, purity and puriﬁca-
tion factor in Table 3 with those in Table 2).
The banding patterns observed in the electrophoretogram of
HGMF fractions (Fig. 10) are qualitatively very similar to those from
the small-scale condition B (Fig. 9) and are entirely consistent with
the process data in Table 3. Bands for Ig cannot be detected in lane
2 (ﬂow through) and the intensity of theRSAband ismuch reduced
cf. lane 1 (startingmaterial). A strongRSAband intensity is restored
in lane 3 (wash) accompanied by faint heavy and light chain Ig
bands. The relative intensities of RSA and Ig bands are reversed in
lanes 4 and5, respectively, correspondingwith theﬁrst and second
cycles of elution.
Calculated Ig desorption eﬃciencies (59.2% for the ﬁrst elution
dropping to 50.5% for the second) were lower than expected
from small-scale studies conductedwith the ‘cleaner’ clariﬁed feed
(see above). Nearly 80% of the ﬁrmly bound Ig was retrieved by
these two HGMF elution cycles (Table 3), but attempts to recover
‘missing’ Ig remaining bound on supports proved unsatisfactory.
While four additional cycles dislodged a further 2.15mgof Ig (8.2%
of that ﬁrmly bound before elution), boosting the overall Ig yield
from 72.4% to 79.9%, Ig purity fell to 60.2% because an extra
12.3mg of protein (22% of that ﬁrmly bound before elution) was
desorbed from the supports. After the last elution cycle had been
completed, the ‘charge’ of magnetic particles within the HGMF
systemwas ﬂushed out and the ﬁlter was dismantled for cleaning.
Visual inspection of the unrolled ﬁlter matrix conﬁrmed the trace
presence of magnetic particles, but no biological fouling material
was evident.
Limitations of HGMF system employed
The main advantage of the mini-pilot-scale cyclically operated
‘ON–OFF’ permanent magnet based HGMS used in this work is
that it allows demonstration of the HGMF concept with small vol-
umes of feedstock. Despite the inherent novelty of its design, it
does not reﬂect the current ‘state-of-the-art’. In commonwith ear-
lier studies19,20,22–26,41,42 the system used in this work employs a
canister packed with amatrix of ferromagnetic wires and an extra-
corporeal recycle loop for conducting washing and elution cycles
when the ﬁeld is switched ‘OFF’. While this design is capable of
delivering high particle separation eﬃciencies from complex feed
streams and aﬀords powerful demonstrations of the processing
speed and capabilities of HGMF for recovering candidate protein
targets from highly complex unclariﬁed bioprocess feedstocks,
as illustrated in this study, it does not lend itself to multi-cycle
operation26 and potential exploitation at large scale.15,21
Two weaknesses of the ‘ﬁxed ﬁlter matrix + recycle loop’ device
are apparent from thework conducted here. First, themuchhigher
product and support concentrations employed in this work cf.
previous studies,18,20,23–26,41,42 rendered concentration on elution
impossible. Loading of the ‘feedstock + particle’ cocktail into
the ﬁlter took just 25 s. Although particles were concentrated
nearly threefold within the ﬁlter, following two steps of elution,
which recovered 80% of the adsorbed Ig, the combined eluate’s Ig
concentration was 3.7-fold more dilute than that of the feed (i.e.
0.67 cf. 2.5mgmL-1). Second, in the ‘ﬁxed ﬁlter matrix + recycle
loop’ design, adsorbents are ﬂushed out of the ﬁlter matrix and
mixedwith eluant by recirculating the resulting suspension at high
velocity around the canister–loop circuit. For product elution from
the adsorbent particles to be eﬀective, eﬃcient particle release
from matrix wires must occur. The reduced elution eﬃciency
identiﬁed above, combined with detection of adsorbent particles
within the ﬁlter at the end of the experiment, point to incomplete
particle release.
Rotor–stator HGMS
The aforementioned problems, additional related issues and
requirements for automated multicycle operation and cGMP
compliance have driven the development of the automated
rotors–stator magnetic ﬁlters.9,15,21,27 Rotor–stator HGMS devices
feature two sets of alternating perforated stainless steel ﬁlter
discs – one set can be rotated at high speed and the other is
stationary. The design is highly eﬀective at re-slurrying attached
magnetic particles at zero ﬁeld, aﬀords high particle collection
capacities (>200 g per litre of ﬁlter) and continuous multi-cycle
operation without loss in performance from one operating cycle
to the next. All washing and elution steps are conducted within
the separator, eliminating the need for extracorporeal recycle
loops or external vessels, leading to reduced buﬀer consumption,
simpler and faster operation. Against the above, it is reasonable to
conclude that had a modern rotor–stator HGMS been employed
to recover and process product laden type III MEP-linkedmagnetic
adsorbents from the same feedstock, all aspects of Ig puriﬁcation
performance by HGMF would have markedly improved.
CONCLUSIONS
An HGMF process for the recovery of rabbit Ig from unclariﬁed
antiserum using MEP-linked non-porous superparamagnetic
adsorbents has been developed. Unconditioned ultra-high titre
bioprocess liquors present stern challenges to adsorptive sepa-
ration techniques, and though speciﬁcally designed for capture
from crude complex feeds, HGMF is not immune to these. To
recover >90% of the Ig present in raw unclariﬁed serum (25 g Ig
per L; 93 g protein per L) would require ∼0.3 g type III MEP- linked
adsorbent per mL, which is roughly 3-fold higher than both the
adsorbent holding capacity of the magnetic ﬁlter used in this
work and the support’s sediment density.48 Because of this anti-
serum was diluted tenfold bringing the target Ig titre to 2.5 g L-1,
a level similar to that of monoclonal antibody-containing culture
broths.12 Greater than 95% of the Ig present in this unclariﬁed
feed was adsorbed at a working Ig binding capacity of 75mgg-1,
and after a brief washing step 80% of the bound Ig was recovered
in two elution cycles in more than threefold puriﬁed form (81%
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uncorrected; 90% corrected) appropriate for immunodiagnostic
use. The whole process took 0.5 h, but considerable time savings
(principally by reducing the binding time) are clearly possible
without sacriﬁcing puriﬁcation performance.
To copewith higher Ig titres found in animal sera, human plasma
and highly expressing CHO cultures, more selective adsorption is
required to make full use of the available surface area for target
binding (200–250mgg-1 with present magnetic support design)
thereby reducing the amounts of magnetic support required to
treat a given feed. This could be achieved either through the prior
and/or post addition of sodium caprylate39,47 to reduce serum
albumin adsorption (the potential downsides here are reduced
Ig yield and compromised isolation of other targets), boosting
the immobilised ligand density – perhaps through grafting of
ligand-bearing polymers or dendrons,15,49 and/or use of more
potent ‘capture’ ligands.12,36
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